Since it is reported in literature that the leptin effects are mediated by MAPK signaling pathway in thyroid cancer [11], here we evaluated whether the pharmacological inhibition of BRAF impairs the combined effects of the two adipokines on thyroid cancer cell proliferation. Here, BRAF is linked to thyroid cancer.